Galectin Therapeutics Inc. (GALT) Earnings
NASDAQ·Healthcare·Biotechnology
$2.34
-1.48%
Mkt Cap $215.98M
Next Earnings
In 22 daysThu, May 21, 2026
EPS Estimate
-$0.06
1 analysts
Revenue Estimate
$0
Last quarter: beat by +20.00% on EPS.
GALT reports 2026-05-21 earnings on Thursday, May 21, 2026 (22 days from today). Consensus estimates are EPS -$0.06 and revenue $0.
View GALT earnings dates & historyEPS — Estimate vs Actual
Mkt Cap
$215.98M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.48